Business

Alexandria Real Estate Equities, Inc. Elects Claire Aldridge, PhD, to Board of Directors

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, today announced that the company's board of directors has elected Claire Aldridge, PhD, as an independent director, effective March 14, 2025. The board of directors has also appointed Dr. Aldridge to serve as a member of its Life Science Committee and determined that she is

articleAlexandria Real Estate Equities, Inc.March 6, 20255/company/alexandria-real-estate-equities-inc/news/alexandria-real-estate-equities-inc-133000773
Alexandria Real Estate Equities, Inc. Elects Claire Aldridge, PhD, to Board of Directors

About this update from Alexandria Real Estate Equities, Inc.

[{"type":"text","content":"PASADENA, Calif., March 6, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, today announced that the company's board of directors has elected Claire Aldridge, PhD, as an independent director, effective March 14, 2025. The board of directors has also appointed Dr. Aldridge to serve as a member of its Life Science Committee and determined that she is independent in accordance with New York Stock Exchange listing standards and Securities and Exchange Commission rules. Her term will run until the company's 2025 annual meeting of stockholders.","length":749,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Alexandria Real Estate Equities, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Alexandria Real Estate Equities, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":291,"url":"https://media.zenfs.com/en/prnewswire.com/b550f41bc01f59a4dea5032e09f2e6f8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nSs9lfxH6jxvUBq0.q447A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUxMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b550f41bc01f59a4dea5032e09f2e6f8","width":400,"height":291}},"href":"https://mma.prnewswire.com/media/1930628/Alexandria_Real_Estate_Equities_Logo_v1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Dr. Aldridge's distinguished career in the life science industry spans more than 25 years across biotechnology, venture capital, entrepreneurship, technology commercialization and AI-accelerated therapeutic development," said Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. "Her deep business and scientific experience, which includes facilitating the translation of scientific discoveries into innovative therapies that improve patient lives, will further bolster the combined expertise of our board, and we are honored to welcome her."","length":638,"tagName":"p"},{"type":"text","content":"Dr. Aldridge was the chief strategy officer of Form Bio, the first spinout from the de-extinction and biodiversity company Colossal Biosciences. At Form Bio, Dr. Aldr...

More updates from Alexandria Real Estate Equities, Inc.

Dr. AldridgeSecurities and Exchange CommissionClaire Aldridgelife scienceColossal BiosciencesNYSEventure capitalbiotechnologyDuke University